[1]
M. Hamayal, S. Mahmud, and W. Shahid, “Extended duration linagliptin nanoparticles: a novel, safe and effective future of diabetes treatment?”, J Pak Med Assoc, vol. 74, no. 10, pp. 1916–1917, Sep. 2024.